Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 309

1.

Heart block and acute kidney injury due to hyperparathyroidism-induced hypercalcemic crisis.

Brown TC, Healy JM, McDonald MJ, Hansson JH, Quinn CE.

Yale J Biol Med. 2014 Dec 12;87(4):563-7. eCollection 2014 Dec.

PMID:
25506288
[PubMed - in process]
Free PMC Article
2.

Transcriptome-wide Profiling and Posttranscriptional Analysis of Hematopoietic Stem/Progenitor Cell Differentiation toward Myeloid Commitment.

Klimmeck D, Cabezas-Wallscheid N, Reyes A, von Paleske L, Renders S, Hansson J, Krijgsveld J, Huber W, Trumpp A.

Stem Cell Reports. 2014 Nov 11;3(5):858-75. doi: 10.1016/j.stemcr.2014.08.012. Epub 2014 Sep 25.

PMID:
25418729
[PubMed - in process]
Free PMC Article
3.

Microfluidic-based isolation of bacteria from whole blood for sepsis diagnostics.

Zelenin S, Hansson J, Ardabili S, Ramachandraiah H, Brismar H, Russom A.

Biotechnol Lett. 2014 Nov 21. [Epub ahead of print]

PMID:
25413883
[PubMed - as supplied by publisher]
4.

MGMT promoter methylation is associated with temozolomide response and prolonged progression-free survival in disseminated cutaneous melanoma.

Tuominen R, Jewell R, van den Oord JJ, Wolter P, Stierner U, Lindholm C, Hertzman Johansson C, Lindén D, Johansson H, Frostvik Stolt M, Walker C, Snowden H, Newton-Bishop J, Hansson J, Egyházi Brage S.

Int J Cancer. 2014 Nov 15. doi: 10.1002/ijc.29332. [Epub ahead of print]

PMID:
25400033
[PubMed - as supplied by publisher]
5.

Trends in cutaneous malignant melanoma in Sweden 1997-2011: Thinner tumours and improved survival among men.

Lyth J, Eriksson H, Hansson J, Ingvar C, Jansson M, Lapins J, Månsson-Brahme E, Naredi P, Stierner U, Ullenhag G, Carstensen J, Lindholm C.

Br J Dermatol. 2014 Oct 16. doi: 10.1111/bjd.13483. [Epub ahead of print]

PMID:
25323770
[PubMed - as supplied by publisher]
6.

Benefit of adjuvant interferon alfa-2b (IFN-α) therapy in melanoma patients with high serum MMP-8 levels.

Vihinen P, Tervahartiala T, Sorsa T, Hansson J, Bastholt L, Aamdal S, Stierner U, Pyrhönen S, Syrjänen K, Lundin J, Hernberg M.

Cancer Immunol Immunother. 2014 Oct 16. [Epub ahead of print]

PMID:
25319807
[PubMed - as supplied by publisher]
7.

Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma.

Long GV, Stroyakovskiy D, Gogas H, Levchenko E, de Braud F, Larkin J, Garbe C, Jouary T, Hauschild A, Grob JJ, Chiarion Sileni V, Lebbe C, Mandalà M, Millward M, Arance A, Bondarenko I, Haanen JB, Hansson J, Utikal J, Ferraresi V, Kovalenko N, Mohr P, Probachai V, Schadendorf D, Nathan P, Robert C, Ribas A, DeMarini DJ, Irani JG, Casey M, Ouellet D, Martin AM, Le N, Patel K, Flaherty K.

N Engl J Med. 2014 Nov 13;371(20):1877-88. doi: 10.1056/NEJMoa1406037. Epub 2014 Sep 29.

PMID:
25265492
[PubMed - indexed for MEDLINE]
8.

The effect on melanoma risk of genes previously associated with telomere length.

Iles MM, Bishop DT, Taylor JC, Hayward NK, Brossard M, Cust AE, Dunning AM, Lee JE, Moses EK, Akslen LA; AMFS Investigators, Andresen PA, Avril MF, Azizi E, Scarrà GB, Brown KM, Dębniak T, Elder DE, Friedman E, Ghiorzo P, Gillanders EM, Goldstein AM, Gruis NA, Hansson J, Harland M, Helsing P, Hočevar M, Höiom V; IBD investigators, Ingvar C, Kanetsky PA, Landi MT, Lang J, Lathrop GM, Lubiński J, Mackie RM, Martin NG, Molven A, Montgomery GW, Novaković S, Olsson H, Puig S, Puig-Butille JA; QMEGA and QTWIN Investigators, Radford-Smith GL, Randerson-Moor J; SDH Study Group, van der Stoep N, van Doorn R, Whiteman DC, MacGregor S, Pooley KA, Ward SV, Mann GJ, Amos CI, Pharoah PD, Demenais F, Law MH, Newton Bishop JA, Barrett JH; GenoMEL Consortium.

J Natl Cancer Inst. 2014 Sep 17;106(10). pii: dju267. doi: 10.1093/jnci/dju267. Print 2014 Oct.

PMID:
25231748
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Strategies to facilitate implementation and sustainability of large system transformations: a case study of a national program for improving quality of care for elderly people.

Nyström ME, Strehlenert H, Hansson J, Hasson H.

BMC Health Serv Res. 2014 Sep 18;14:401. doi: 10.1186/1472-6963-14-401.

PMID:
25230774
[PubMed - in process]
Free PMC Article
10.

Use of Scandinavian moist smokeless tobacco (snus) and the risk of atrial fibrillation.

Hergens MP, Galanti R, Hansson J, Fredlund P, Ahlbom A, Alfredsson L, Bellocco R, Eriksson M, Fransson EI, Hallqvist J, Jansson JH, Knutsson A, Pedersen N, Lagerros YT, Ostergren PO, Magnusson C.

Epidemiology. 2014 Nov;25(6):872-6. doi: 10.1097/EDE.0000000000000169.

PMID:
25166877
[PubMed - in process]
11.

Identification of regulatory networks in HSCs and their immediate progeny via integrated proteome, transcriptome, and DNA Methylome analysis.

Cabezas-Wallscheid N, Klimmeck D, Hansson J, Lipka DB, Reyes A, Wang Q, Weichenhan D, Lier A, von Paleske L, Renders S, Wünsche P, Zeisberger P, Brocks D, Gu L, Herrmann C, Haas S, Essers MA, Brors B, Eils R, Huber W, Milsom MD, Plass C, Krijgsveld J, Trumpp A.

Cell Stem Cell. 2014 Oct 2;15(4):507-22. doi: 10.1016/j.stem.2014.07.005. Epub 2014 Aug 21.

PMID:
25158935
[PubMed - in process]
12.

Feasibility of ballistic strengthening exercises in neurologic rehabilitation.

Williams G, Clark RA, Hansson J, Paterson K.

Am J Phys Med Rehabil. 2014 Sep;93(9):828-33. doi: 10.1097/PHM.0000000000000139.

PMID:
25137195
[PubMed - in process]
13.

Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial.

Olofsson R, Ny L, Eilard MS, Rizell M, Cahlin C, Stierner U, Lönn U, Hansson J, Ljuslinder I, Lundgren L, Ullenhag G, Kiilgaard JF, Nilsson J, Lindnér P.

Trials. 2014 Aug 9;15:317. doi: 10.1186/1745-6215-15-317.

PMID:
25106493
[PubMed - in process]
Free PMC Article
14.

Fine mapping of genetic susceptibility loci for melanoma reveals a mixture of single variant and multiple variant regions.

Barrett JH, Taylor JC, Bright C, Harland M, Dunning AM, Akslen LA, Andresen PA, Avril MF, Azizi E, Bianchi Scarrà G, Brossard M, Brown KM, Dębniak T, Elder DE, Friedman E, Ghiorzo P, Gillanders EM, Gruis NA, Hansson J, Helsing P, Hočevar M, Höiom V, Ingvar C, Landi MT, Lang J, Lathrop GM, Lubiński J, Mackie RM, Molven A, Novaković S, Olsson H, Puig S, Puig-Butille JA, van der Stoep N, van Doorn R, van Workum W, Goldstein AM, Kanetsky PA, Pharoah PD, Demenais F, Hayward NK, Newton Bishop JA, Bishop DT, Iles MM; on behalf of the GenoMEL Consortium.

Int J Cancer. 2014 Jul 31. doi: 10.1002/ijc.29099. [Epub ahead of print]

PMID:
25077817
[PubMed - as supplied by publisher]
15.

Primary Melanoma Tumors from CDKN2A Mutation Carriers Do Not Belong to a Distinct Molecular Subclass.

Staaf J, Harbst K, Lauss M, Ringnér M, Måsbäck A, Howlin J, Jirström K, Harland M, Zebary A, Palmer JM, Ingvar C, Olsson H, Newton-Bishop J, Hansson J, Hayward N, Gruis N, Jönsson G; Melanoma Genetics Consortium (GenoMEL).

J Invest Dermatol. 2014 Dec;134(12):3000-3. doi: 10.1038/jid.2014.272. Epub 2014 Jul 7. No abstract available.

PMID:
24999598
[PubMed - in process]
16.

A phase I clinical trial combining dendritic cell vaccination with adoptive T cell transfer in patients with stage IV melanoma.

Poschke I, Lövgren T, Adamson L, Nyström M, Andersson E, Hansson J, Tell R, Masucci GV, Kiessling R.

Cancer Immunol Immunother. 2014 Oct;63(10):1061-71. doi: 10.1007/s00262-014-1575-2. Epub 2014 Jul 4.

PMID:
24993563
[PubMed - in process]
17.

Myeloid-derived suppressor cells and their role in CTLA-4 blockade therapy.

Pico de Coaña Y, Masucci G, Hansson J, Kiessling R.

Cancer Immunol Immunother. 2014 Sep;63(9):977-83. doi: 10.1007/s00262-014-1570-7. Epub 2014 Jun 26.

PMID:
24966003
[PubMed - indexed for MEDLINE]
18.

Laminins 411 and 421 differentially promote tumor cell migration via α6β1 integrin and MCAM (CD146).

Ishikawa T, Wondimu Z, Oikawa Y, Gentilcore G, Kiessling R, Egyhazi Brage S, Hansson J, Patarroyo M.

Matrix Biol. 2014 Sep;38:69-83. doi: 10.1016/j.matbio.2014.06.002. Epub 2014 Jun 18.

PMID:
24951930
[PubMed - in process]
Free Article
19.

High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families.

Helgadottir H, Höiom V, Jönsson G, Tuominen R, Ingvar C, Borg A, Olsson H, Hansson J.

J Med Genet. 2014 Aug;51(8):545-52. doi: 10.1136/jmedgenet-2014-102320. Epub 2014 Jun 16.

PMID:
24935963
[PubMed - in process]
Free PMC Article
20.

MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: A pooled-analysis from the M-SKIP project.

Pasquali E, García-Borrón JC, Fargnoli MC, Gandini S, Maisonneuve P, Bagnardi V, Specchia C, Liu F, Kayser M, Nijsten T, Nagore E, Kumar R, Hansson J, Kanetsky PA, Ghiorzo P, Debniak T, Branicki W, Gruis NA, Han J, Dwyer T, Blizzard L, Landi MT, Palmieri G, Ribas G, Stratigos A, Council ML, Autier P, Little J, Newton-Bishop J, Sera F, Raimondi S; M-SKIP Study Group.

Int J Cancer. 2015 Feb 15;136(3):618-31. doi: 10.1002/ijc.29018. Epub 2014 Jun 18.

PMID:
24917043
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk